Actively Recruiting
Impact of a Clinical Pathway for Pelvic Fragility Fractures
Led by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Updated on 2024-06-24
393
Participants Needed
8
Research Sites
170 weeks
Total Duration
On this page
Sponsors
A
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Lead Sponsor
N
Noordwest Ziekenhuisgroep
Collaborating Sponsor
AI-Summary
What this Trial Is About
Patients with pelvic fragility fractures suffer from high morbidity and mortality rates. Despite the high incidence of these injuries, there is currently no regional or nationwide treatment protocol which results in a wide variety of clinical practice. New insights in treatment strategies, such as early diagnosis and minimal invasive operative treatment of these fragile patient population, has led to the development of several clinical pathways in recent literature. The aim of this study is to implement an evidence and experience-based treatment clinical pathway to improve the outcomes in this fragile patient population that currently has multifactorial risks for poor outcome.
CONDITIONS
Official Title
Impact of a Clinical Pathway for Pelvic Fragility Fractures
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pelvic fragility fracture caused by low energetic trauma
- Patients presented at the emergency room or out-patient clinic of a participating hospital
You will not qualify if you...
- Patients with high suspicion of a pelvic fracture due to a malignant tumor
- Patients who are unable to follow instructions due to severe cognitive decline (for example due to dementia or Alzheimer's disease)
- Patients who pre-trauma received palliative or terminal care
- Patients who pre-trauma were wheelchair bound or bedridden
- Patients who suffer from complications from previous pelvic ring fixation
- Patients with insufficient comprehension of the Dutch language to be able to carry out the physiotherapy instructions for early mobilization
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 8 locations
1
Flevoziekenhuis
Almere Stad, Flevoland, Netherlands, 1315 RA
Actively Recruiting
2
Noordwest Ziekenhuisgroep
Alkmaar, North Holland, Netherlands, 1815 JD
Actively Recruiting
3
BovenIJ ziekenhuis
Amsterdam, North Holland, Netherlands, 1034 CS
Actively Recruiting
4
OLVG
Amsterdam, North Holland, Netherlands, 1061 AE
Actively Recruiting
5
Amsterdam UMC
Amsterdam, North Holland, Netherlands, 1105 AZ
Actively Recruiting
6
Spaarne Gasthuis
Haarlem, North Holland, Netherlands, 2035 RC
Actively Recruiting
7
Dijklander Ziekenhuis
Hoorn, North Holland, Netherlands, 1624 NP
Actively Recruiting
8
Zaans Medisch Centrum
Zaandam, North Holland, Netherlands, 1502 DV
Actively Recruiting
Research Team
D
Daphne van Embden, MD, PhD
CONTACT
A
Anna H. Mennen, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here